Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1

Name: Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1
License: Public Domain

Shi Yuankai

ClinicalTrials.gov · Datasets · License: Public Domain

head and neck squamous cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 146480
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.